MRK
NYSE Merck & Co., Inc.$148.69 ↑ +0.00 (+0.00%) Trading Up from the previous close of $148.69, $0.50 below the day’s high of $149.19
- YTD change
- +41.26%
- vs 20-day SMA
- +0.54%
- vs 200-day SMA
- +22.21%
Price ranges
Price & Performance
+30.59 (+25.90%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 5.2% away from all-time highs of $156.92
- MRK is up 41% since the beginning of the year
- MRK is up 89% over the past 12 months
- MRK is down 1% over the past 1 month
- 1% of all MRK investors are betting against MRK
- Number of investors short MRK has gone up 22% versus last month
MRK reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +89.2%.
- Previous minute
- +$0.00
- Last hour
- -$0.41
- Last 5 days
- +1.24%
- vs 8-day SMA
- +0.45%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.